Dr. David Baker to address Germany’s National Academy of Sciences
Dr. David Baker to address Germany’s National Academy of Sciences
David Baker, professor of education and sociology, has been invited to address the Leopoldina, Germany’s National Academy of Science, in Berlin in June.
Baker was asked to speak on the topic “Education, World Health and Brain Power” and will present his research on the impact of the education revolution on cognition and world health and societal development. The talk is a part of the Leopoldina’s focus on Brain Power for Sustainable Development.
Founded in 1652, the Leopoldina is one of the oldest academies of science in the world and has been the German National Academy of Sciences since 2008. The Leopoldina brings together the expertise of some 1,500 distinguished scientists to bear on questions of social and political relevance, publishing unbiased and timely scientific opinions and represents the German scientific community in international committees and pursues the advancement of science for the benefit of humankind and for a better future.
SSRI provided seed funding for Baker’s research.
David Baker, professor of education and sociology, has been invited to address the Leopoldina, Germany’s National Academy of Science, in Berlin in June.
Baker was asked to speak on the topic “Education, World Health and Brain Power” and will present his research on the impact of the education revolution on cognition and world health and societal development. The talk is a part of the Leopoldina’s focus on Brain Power for Sustainable Development.
Founded in 1652, the Leopoldina is one of the oldest academies of science in the world and has been the German National Academy of Sciences since 2008. The Leopoldina brings together the expertise of some 1,500 distinguished scientists to bear on questions of social and political relevance, publishing unbiased and timely scientific opinions and represents the German scientific community in international committees and pursues the advancement of science for the benefit of humankind and for a better future.
SSRI provided seed funding for Baker’s research.